SNPS

Synopsys
D

SNPS

Arincen72/100B

Synopsys return on equity (ROE)

Synopsys's return on equity is 3.45%: net income of 1.08B USD over the last twelve months on shareholders' equity of 31.15B USD.

Today
3.45%
Average, 5 years
15.28%
Low, 5 years
2.53%
High, 5 years
24.87%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 1.08B ÷ 31.15B = 3.45%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

What drives Synopsys's return on equity?

Net margin
18.9%
profit on each dollar of sales
Asset turnover
0.15×
sales on each dollar of assets
Equity multiplier
1.70×
assets on each dollar of equity
Return on equity
4.7%
FY2025
  • FY202518.9% × 0.15 × 1.70 = 4.7%
  • FY202436.9% × 0.47 × 1.45 = 25.2%
  • FY202323.1% × 0.51 × 1.68 = 20.0%
  • FY202221.3% × 0.49 × 1.71 = 17.9%
  • FY202118.0% × 0.48 × 1.65 = 14.3%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today3.45%1.08B31.15B
FY202531 Oct 20254.71%1.33B28.33B
FY202431 Oct 202424.87%2.24B8.99B
FY202331 Oct 202319.82%1.22B6.15B
FY202231 Oct 202217.74%978.44M5.52B
FY202131 Oct 202114.28%756.36M5.30B
FY202031 Oct 202013.52%663.45M4.91B
FY201931 Oct 201913.04%532.37M4.08B
FY201831 Oct 201812.43%432.52M3.48B
FY201731 Oct 20174.17%136.56M3.28B
FY201631 Oct 20168.35%266.83M3.20B
FY201531 Oct 20157.21%225.93M3.13B
FY201431 Oct 20148.48%259.12M3.06B
FY201331 Oct 20138.89%247.80M2.79B
FY201231 Oct 20127.29%182.40M2.50B
FY201131 Oct 201110.53%221.36M2.10B
FY201031 Oct 201011.29%237.06M2.10B
FY200931 Oct 20099.09%167.68M1.84B
FY200831 Oct 200812.43%189.98M1.53B
FY200731 Oct 20079.08%130.49M1.44B
FY200631 Oct 20062.13%24.74M1.16B
FY200531 Oct 2005-1.40%-17.11M1.22B
FY200431 Oct 20045.88%74.34M1.27B
FY200331 Oct 200310.45%149.72M1.43B
FY200231 Oct 2002-17.96%-199.99M1.11B
FY200131 Oct 200111.70%56.80M485.66M
FY200031 Oct 200014.32%97.78M682.83M
FY199930 Sept 199918.65%161.40M865.60M
FY199830 Sept 19989.59%63.30M660.40M
FY199730 Sept 199719.91%82.00M411.80M
FY199630 Sept 19967.22%16.80M232.70M
FY199530 Sept 199516.62%30.30M182.30M
FY199430 Sept 199413.05%15.80M121.10M
FY199330 Sept 199316.06%13.20M82.20M
FY199230 Sept 199212.22%7.10M58.10M
FY199130 Sept 199116.75%3.50M20.90M
FY199030 Sept 199030.25%3.60M11.90M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Debt to equity,Current ratio,All ratios

Common questions about Synopsys's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.